Denise M Boudreau

Biographic Data

ID5540154
NAMEDenise M Boudreau
GIVEN NAMESDenise M
FAMILY NAMEBoudreau
SIGNATUREBOUDREAU D M
AFFILIATIONSGroup Health Cooperative
ORCID0000-0003-4300-4901
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS13
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2005
LATEST PUBLICATION YEAR2015
H-INDEX1

  • Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash

    Ryan N Hansen, Denise M Boudreau et al.ARTICLEAmerican Journal of Public Health2015References: 30

    Objectives. We sought to estimate the association between sedative hypnotic use and motor vehicle crash risk. Methods. We conducted a new user cohort study of 409 171 adults in an integrated health care system. Health plan data were linked to driver license and collision records. Participants were aged 21 years or older, licensed to drive in Washington State, had at least 1 year of continuous enrollment between 2003 and 2008, and were followed un…

  • Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer Pain

    Cynthia I Campbell, Constance Weisner et al.ARTICLEAmerican Journal of Public Health2010Cited by: 13References: 29

    Objectives. We describe age and gender trends in long-term use of prescribed opioids for chronic noncancer pain in 2 large health plans. Methods. Age- and gender-standardized incident (beginning in each year) and prevalent (ongoing) opioid use episodes were estimated with automated health care data from 1997 to 2005. Profiles of opioid use in 2005 by age and gender were also compared. Results. From 1997 to 2005, age–gender groups exhibited a tota…

  • Cost of Breast-Related Care in the Year Following False Positive Screening Mammograms

    Jessica Chubak, Denise M Boudreau et al.ARTICLEMedical Care2010References: 28

    OBJECTIVE: We sought to estimate the direct cost, from the perspective of the health insurer or purchaser, of breast-care services in the year following a false positive screening mammogram compared with a true negative examination. DESIGN: We identified 21,125 women aged 40 to 80 years enrolled in an integrated healthcare delivery system in Washington State, who participated in screening mammography between January 1, 1998 and July 30, 2002. Pat…

  • Quality of life valuations of mammography screening

    Open AccessAmy E Bonomi, Denise M Boudreau et al.ARTICLEQuality of Life Research2008

  • Cluster Randomized Trials: Opportunities and Barriers Identified by Leaders of Eight Health Plans

    Kathleen M Mazor, James E Sabin et al.ARTICLEMedical Care2007References: 17

    BACKGROUND: Cluster randomized trials (CRTs) offer unique advantages over standard randomized controlled clinical trials (RCTs) and observational methodologies, and may provide a cost-efficient alternative for answering questions about the best treatments for common conditions. OBJECTIVES: To describe health plan leaders' views on CRTs, identify barriers to conducting CRTs, and solicit recommendations for increasing the acceptability of CRTs. RES…

  • Impact of Hormone Therapy on False-Positive Recall and Costs Among Women Undergoing Screening Mammography

    Denise M Boudreau, Diana S M Buist et al.ARTICLEMedical Care2006References: 40

    OBJECTIVE: We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs. DESIGN: We undertook an observational cohort study of women ages 40-80 years with 2 mammography screenings in an integrated delivery system. MEASURES: FP recall, defined as mammograms resulting in a radiologist's recommendation for additional imaging, ultrasound, or invasive procedures among disease-free w…

  • Family-level cost-effectiveness analysis: Response to Holmes’ commentary

    Open AccessAmy E Bonomi, Paul Fishman et al.ARTICLEQuality of Life Research2005

  • Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis

    Open AccessAmy E Bonomi, Denise M Boudreau et al.ARTICLEQuality of Life Research2005